Browsing Tag
Michael Chancellor
2 posts
Breakthrough in oral lichen planus? Lipella Pharmaceuticals’ LP-310 delivers promising results
Lipella Pharmaceuticals has announced encouraging topline results from its Phase 2a dose-ranging trial for LP-310, a liposomal-tacrolimus oral…
Lipella Pharmaceuticals secures FDA approval for expanded access program for LP-310 in oral lichen planus
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company dedicated to addressing unmet medical needs, has announced that it has…